Identifying prognostic and predictive value of mutations associated with clinical outcomes in first line (1L) patients with advanced or metastatic non-small cell lung cancer (aNSCLC).

被引：0
|
作者：
Perez Parente, Diego
Cobo-Dols, Manuel
Hasan, Haroon
Olson, Sara
Pal, Navdeep
Wilkinson, Samantha
La Orden Tevar, Beatriz
Perez Fernandez, Mar
Provencio-Pulla, Mariano
机构：
[1] Roche Farma, Lung Canc Squad, Madrid, Spain
[2] Hosp Univ Reg Malaga, Malaga, Spain
[3] Genentech Inc, Product Dev Data Sci, San Francisco, CA USA
[4] Roche Prod Ltd, Welwyn Garden City, Herts, England
[5] Hosp Univ Puerta Hierro Majadahonda, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9047
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CLINICAL OUTCOMES OF FIRST-LINE (1L) TREATMENTS (Txs) IN LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (aNSCLC): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Reck, M.
    Soo, R. A.
    Coaquira, Castro J.
    Chaudhary, T.
    Finn, E.
    Xu, W.
    Zhan, L.
    VALUE IN HEALTH, 2024, 27 (06) : S44 - S44
  • [2] Real-world survival with first-line (1L) chemotherapy in patients (pts) with advanced non-small cell lung cancer (aNSCLC)
    Waterhouse, D.
    Betts, K. A.
    Zhao, J.
    Rao, S.
    Gupte-Singh, K.
    Rutstein, M.
    Higashi, M. K.
    Schwartzberg, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 29 - U99
  • [3] Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer
    Provencio-Pulla, Mariano
    Perez-Parente, Diego
    Olson, Sara
    Hasan, Haroon
    Balea, Begona Campos
    Rodriguez-Abreu, Delvys
    Piqueras, Marta Lopez-Brea
    Pal, Navdeep
    Wilkinson, Samantha
    Vilas, Esther
    Ruiz-Gracia, Pedro
    Cobo-Dols, Manuel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (06): : 1384 - 1394
  • [4] Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
    Sun, Jong-Mu
    Hwang, Deok Won
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    PLOS ONE, 2013, 8 (05):
  • [5] PROGNOSTIC AND PREDICTIVE VALUE OF KRAS MUTATIONS IN ADVANCED NON-SMALL CELL LUNG CANCER
    Hwang, Deok Won
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1075 - S1075
  • [6] Comparative Effectiveness of First Line (1L) Therapies for Advanced Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)
    Goring, S.
    Li, T.
    Gara, A.
    Varol, N.
    Korytowsky, B.
    Hertel, N.
    Baas, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S356 - S357
  • [7] COSTS OF CARE FOR FIRST-LINE (1L) TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC): A REAL-WORLD CLAIMS ANALYSIS
    Kish, Jonathan
    Chopra, Dhruv
    Liassou, Djibril
    Lubinga, Solomon
    Hartman, John
    Feinberg, Bruce
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A437 - A438
  • [8] Genomic characterization of first line advanced or metastatic non-small cell lung cancer (aNSCLC) patients (pts) subgroups associated with good/bad prognosis
    Provencio Pulla, M.
    Perez Parente, D.
    Campos Balea, B.
    Rodriguez Abreu, D.
    Hasan, H.
    Olson, S.
    Pal, N.
    Wilkinson, S.
    De Oro Pulido, F.
    Ruiz Gracia, P.
    Cobo Dols, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1040 - S1041
  • [9] First-line (1L) nivolumab (NIVO) plus ipilimumab (IPI) in Asian patients (pts) with advanced non-small cell lung cancer (aNSCLC) in CheckMate 227
    O'Byrne, K. J.
    Lee, K. H.
    Kim, S-W.
    Park, K.
    Nishio, M.
    Sakai, H.
    Ohe, Y.
    Fukuhara, T.
    Kang, J-H.
    Daga, H.
    Yu, C-J.
    Hotta, K.
    Tanaka, H.
    Takeda, M.
    Yokoyama, T.
    Nathan, F. E.
    Lee, J-S.
    ANNALS OF ONCOLOGY, 2020, 31 : S824 - S824
  • [10] Nivolumab beyond First-Line (1L) Treatment in Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Sotelo, Miguel
    Chara, Luis
    Riquelme, Alejandro
    Toro, Piedad
    Lopez, Cynthia
    Hernando, Susana
    Caviedes, Edinson
    Aguayo, Cristina
    Bueno, Coralia
    Mielgo Rubio, Xabier
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1340 - S1341
12345